CUA Educational Content

CUA Call-to-Action: Advanced Prostate Cancer (mCSPC)

Speakers: Andrea Kokorovic, Tamim Niazi, Ricardo Rendon & Christopher Wallis

Objectives

By the end of this program, participants can expect to:

  • Review the general management of patients with mCSPC
  • Discuss multi-disciplinary strategies in managing patients with mCSPC
  • Understand the monitoring and system economic burden ARPIs
  • Summarize the major adverse events associated with mPCa treatments
  • Review the evidence-based strategies to mitigate the AEs associated with ADT and ARPIs
  • Discuss the role of sequencing versus early intensification in patient outcomes
  • Discuss the role of novel imaging modalities in mCSPC
  • Review the role of radiation oncology in management of oligometastatic disease
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1.5 hours of credit.

This program has received financial support from Bayer & Tolmar in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy